Please enable Javascript to get a taste of that Hopium 👼

AMGN - Financials Overview - Amgen Inc

Financials

We've grouped the latest 4 financial reports for AMGN. You can view and compare their Income Statement, Balance Sheet, and Cash Flow.

Income Statement2018201920202021
Total Revenue$23.7B$23.4B$25.4B$50.8B
Cost of Revenue$5.32B$5.51B$7.34B$14.4B
Gross Margin$18.4B$17.8B$18.1B$36.4B
Research & Development$3.74B$4.12B$4.21B$6.32B
Selling, General and Administrative----
Other Operating Expense----
Total Operating Expense----
Operating Income$10.3B$9.67B$9.14B$7.64B
Interest Income$674M$753M$256M-
Interest Expense$1.39B$1.29B$1.26B$1.20B
Net Interest Incomee-$1.39B-$1.29B-$1.26B-$1.20B
Other Income Expense----
Non-recurring Items----
Other Non-operating Income$674M$753M$256M$259M
Income before Provision for income taxes$9.55B$9.14B$8.13B$6.70B
Tax Provision$1.15B$1.30B$869M$808M
Net Income$8.39B$7.84B$7.26B$5.89B
Effect of accounting charges----
Minority Interest----
Provision for income taxes----
Non-recurring items----
Other Items----
Discontinued Operations----
Preferred Stock Dividends----
EBIT$10.3B$9.67B$9.14B$7.64B
Balance Sheet2018201920202021
otherNonCurrentAssets----
Assets
Cash, Cash Equivalents & Short-term investments$29.5B$9.21B$11.1B$8.87B
Cash & Cash Equivalents----
Other Short-term Investments$22.5B$3.18B$4.86B$879M
Receivables----
Inventory$2.94B$3.58B$3.89B$4.09B
Other Current Assets$1.79B$1.89B$2.08B$2.37B
Total Current Assets$37.6B$18.4B$21.1B$19.4B
PPE$4.96B$4.93B$4.89B$5.18B
Non-current Marketable Securities$683M$799M--
total non-current assets$28.8B$41.7B$42.2B$42.3B
Goodwill$14.7B$14.7B$14.7B$14.9B
Other Intangible Assets$22.1B$34.1B$31.3B$30.1B
deferred long-term asset charges----
Total Assets$66.4B$59.7B$62.9B$61.2B
Liabilities
Accounts Payable----
Current Debt$4.42B$2.95B$91.0M$87.0M
Other Current Liabilties$7.86B$8.51B$10.1B$10.7B
Total Current Liabilities$13.5B$12.8B$11.7B$12.2B
Long Term Debt$33.9B$29.9B$33.0B$33.3B
Non-Current Deferred Liabilties----
Negative Goodwill----
Other Non-Current Liabilities$1.28B$2.21B$2.02B$2.47B
total non-current liabilities$40.4B$37.0B$42.2B$42.8B
Total capital lease obligations----
Total Liabilities$53.9B$50.0B$53.5B$54.5B
Shareholder's Equity
Common Stock----
Share premium----
Preferred Stock----
Retained Earnings----
Additional Paid-in Capital----
Gains/Losses not affecting retained earnings----
Treasury Stock----
Total Shareholders' Equity$12.5B$9.67B$9.41B$6.70B
Total Liabilities and Shareholders' Equity----
Cash Flow2018201920202021
Cash from Operating Activities
Operating Activities$11.3B$9.15B$10.5B$9.26B
Other Operating Activities----
Change(increase) in Operating Activities----
Net Income$8.39B$7.84B$7.26B$5.89B
Depreciation----
Change in Liabilities----
Change in Inventory$3.00M$66.0M$215M$165M
Change(increase) in Account Receivables----
Change(increase) in Receivables$378M$504M$427M$429M
Cash from Investing Activities
Investment Activities$14.3B$5.71B-$5.40B$733M
Other Investment Activities----
Investments----
Capital Expenditures$738M$618M$608M$880M
Cash from Financing Activities
Financing Activities-$22.5B-$15.8B-$4.87B-$8.27B
Other Financing Activities----
Stock Sale and Purchase----
Dividends$3.51B$3.51B$3.76B$4.01B
Net Borrowings----
Change(increase) in Cash----
Change(increase) in Cash and Cash Equivalents$3.15B-$908M$229M$1.72B
Change(increase) in Net Income----
Change in Exchange Rate----
Data source(s): Alpha Vantage